{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:06:22Z","timestamp":1779242782790,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13159-z","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:37:09Z","timestamp":1774528629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of mRNA expressions in nasopharyngeal and oropharyngeal swab samples in active SARS-CoV-2 infection and after SARS-CoV-2 infection"],"prefix":"10.1186","volume":"26","author":[{"given":"Burcu","family":"\u00c7aykara Peran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcler","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadrettin","family":"Pen\u00e7e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurettin","family":"Yiyit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burhanettin","family":"Yal\u00e7\u0131nkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"1","key":"13159_CR1","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/S2666-5247(20)30172-5","volume":"2","author":"M Cevik","year":"2021","unstructured":"Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021;2(1):e13\u201322. https:\/\/doi.org\/10.1016\/S2666-5247(20)30172-5.","journal-title":"Lancet Microbe"},{"issue":"3","key":"13159_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019kovski","year":"2021","unstructured":"V\u2019kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155\u201370. https:\/\/doi.org\/10.1038\/s41579-020-00468-6.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"13159_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420\u20132. https:\/\/doi.org\/10.1016\/S2213-2600(20)30076-X.","journal-title":"Lancet Respir Med"},{"key":"13159_CR4","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","volume":"109","author":"HA Rothan","year":"2020","unstructured":"Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. https:\/\/doi.org\/10.1016\/j.jaut.2020.102433.","journal-title":"J Autoimmun"},{"key":"13159_CR5","doi-asserted-by":"publisher","first-page":"100682","DOI":"10.1016\/j.genrep.2020.100682","volume":"19","author":"RA Khailany","year":"2020","unstructured":"Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Rep. 2020;19:100682. https:\/\/doi.org\/10.1016\/j.genrep.2020.100682.","journal-title":"Gene Rep"},{"issue":"4","key":"13159_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586\u201390. https:\/\/doi.org\/10.1007\/s00134-020-05985-9.","journal-title":"Intensive Care Med"},{"key":"13159_CR7","doi-asserted-by":"publisher","unstructured":"Wang X, Dhindsa R, Povysil G, Zoghbi A, Motelow J, Hostyk J, et al. Transcriptional inhibition of host viral entry proteins as a therapeutic strategy for SARS-CoV-2. 2020. https:\/\/doi.org\/10.20944\/preprints202003.0360.v1.","DOI":"10.20944\/preprints202003.0360.v1"},{"key":"13159_CR8","doi-asserted-by":"publisher","unstructured":"Eldien HMS, Almaeen AH, El Fath AA, Taha AE, Ahmed R, Elfadil H, et al. Unlocking the potential of RNA sequencing in COVID-19: toward accurate diagnosis and personalized medicine. Diagnostics (Basel). 2025;15(2):229. Published 2025 Jan 20. https:\/\/doi.org\/10.3390\/diagnostics15020229.","DOI":"10.3390\/diagnostics15020229"},{"key":"13159_CR9","doi-asserted-by":"publisher","first-page":"1407261","DOI":"10.3389\/fcimb.2024.1407261","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Chen S, Tian Y, Fu X. Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects. Front Cell Infect Microbiol. 2024;14:1407261. https:\/\/doi.org\/10.3389\/fcimb.2024.1407261. Published 2024 May 22.","journal-title":"Front Cell Infect Microbiol"},{"key":"13159_CR10","doi-asserted-by":"publisher","first-page":"1355809","DOI":"10.3389\/fcimb.2024.1355809","volume":"14","author":"HBDS Grisard","year":"2024","unstructured":"Grisard HBDS, Sch\u00f6rner MA, Barazzetti FH, Wachter JK, Valmorbida M, Wagner G, et al. ACE2 and TMPRSS2 expression in patients before, during, and after SARS-CoV-2 infection. Front Cell Infect Microbiol. 2024;14:1355809. https:\/\/doi.org\/10.3389\/fcimb.2024.1355809. Published 2024 Mar 28.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"13159_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"5","key":"13159_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11906-008-0076-0","volume":"10","author":"MJ Soler","year":"2008","unstructured":"Soler MJ, Barrios C, Oliva R, Batlle D. Pharmacologic modulation of ACE2 expression. Curr Hypertens Rep. 2008;10(5):410\u20134. https:\/\/doi.org\/10.1007\/s11906-008-0076-0.","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"13159_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/infdis\/jiaa332","volume":"222","author":"BGG Pinto","year":"2020","unstructured":"Pinto BGG, Oliveira AER, Singh Y, Jimenez L, Gon\u00e7alves ANA, Ogava RLT, et al. ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19. J Infect Dis. 2020;222(4):556\u201363. https:\/\/doi.org\/10.1093\/infdis\/jiaa332.","journal-title":"J Infect Dis"},{"issue":"1","key":"13159_CR14","doi-asserted-by":"publisher","first-page":"9658","DOI":"10.1038\/s41598-021-88944-8","volume":"11","author":"\u00c1D Rossi","year":"2021","unstructured":"Rossi \u00c1D, de Ara\u00fajo JLF, de Almeida TB, Ribeiro-Alves M, de Almeida Velozo C, Almeida JM, et al. Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress. Sci Rep. 2021;11(1):9658. https:\/\/doi.org\/10.1038\/s41598-021-88944-8.","journal-title":"Sci Rep"},{"key":"13159_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fmed.2020.00334","volume":"7","author":"H Wang","year":"2020","unstructured":"Wang H, Liu Q, Hu J, Zhou M, Yu MQ, Li KY, et al. Nasopharyngeal Swabs Are More Sensitive Than Oropharyngeal Swabs for COVID-19 Diagnosis and Monitoring the SARS-CoV-2 Load. Front Med (Lausanne). 2020;7:334. https:\/\/doi.org\/10.3389\/fmed.2020.00334.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"13159_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10096-020-03972-y","volume":"40","author":"ALM Vlek","year":"2021","unstructured":"Vlek ALM, Wesselius TS, Achterberg R, Thijsen SFT. Combined throat\/nasal swab sampling for SARS-CoV-2 is equivalent to nasopharyngeal sampling. Eur J Clin Microbiol Infect Dis. 2021;40(1):193\u20135. https:\/\/doi.org\/10.1007\/s10096-020-03972-y.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"13159_CR17","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41591-021-01296-8","volume":"27","author":"N Huang","year":"2021","unstructured":"Huang N, P\u00e9rez P, Kato T, Mikami Y, Okuda K, Gilmore RC, et al. SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. 2021;27(5):892\u2013903. https:\/\/doi.org\/10.1038\/s41591-021-01296-8.","journal-title":"Nat Med"},{"issue":"3","key":"13159_CR18","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3390\/ijms23031431","volume":"23","author":"A Drozdzik","year":"2022","unstructured":"Drozdzik A, Drozdzik M. Oral Pathology in COVID-19 and SARS-CoV-2 Infection-Molecular Aspects. Int J Mol Sci. 2022;23(3):1431. https:\/\/doi.org\/10.3390\/ijms23031431.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"13159_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12967-021-03037-4","volume":"19","author":"J Peng","year":"2021","unstructured":"Peng J, Sun J, Zhao J, Deng X, Guo F, Chen L. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells. J Transl Med. 2021;19(1):358. https:\/\/doi.org\/10.1186\/s12967-021-03037-4.","journal-title":"J Transl Med"},{"issue":"8","key":"13159_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/ddr.21729","volume":"81","author":"I Voinsky","year":"2020","unstructured":"Voinsky I, Gurwitz D, Smoking. COVID-19: Similar bronchial ACE2 and TMPRSS2 expression and higher TMPRSS4 expression in current versus never smokers. Drug Dev Res. 2020;81(8):1073\u201380. https:\/\/doi.org\/10.1002\/ddr.21729.","journal-title":"Drug Dev Res"},{"issue":"1","key":"13159_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12931-020-01521-x","volume":"21","author":"M Matusiak","year":"2020","unstructured":"Matusiak M, Sch\u00fcrch CM. Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics. Respir Res. 2020;21(1):252. https:\/\/doi.org\/10.1186\/s12931-020-01521-x.","journal-title":"Respir Res"},{"issue":"10","key":"13159_CR22","doi-asserted-by":"publisher","first-page":"e05143","DOI":"10.1016\/j.heliyon.2020.e05143","volume":"6","author":"F Amati","year":"2020","unstructured":"Amati F, Vancheri C, Latini A, Colona VL, Grelli S, D\u2019Apice MR, et al. Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients. Heliyon. 2020;6(10):e05143. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05143.","journal-title":"Heliyon"},{"issue":"3","key":"13159_CR23","doi-asserted-by":"publisher","first-page":"e0078321","DOI":"10.1128\/Spectrum.00783-21","volume":"9","author":"MR Hasan","year":"2021","unstructured":"Hasan MR, Ahmad MN, Dargham SR, Zayed H, Al Hashemi A, Ngwabi N, et al. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters. Microbiol Spectr. 2021;9(3):e0078321. https:\/\/doi.org\/10.1128\/Spectrum.00783-21.","journal-title":"Microbiol Spectr"},{"issue":"18","key":"13159_CR24","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.cell.2021.07.023","volume":"184","author":"CGK Ziegler","year":"2021","unstructured":"Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, et al. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell. 2021;184(18):4713\u2013e473322. https:\/\/doi.org\/10.1016\/j.cell.2021.07.023.","journal-title":"Cell"},{"issue":"10","key":"13159_CR25","doi-asserted-by":"publisher","first-page":"101585","DOI":"10.1016\/j.isci.2020.101585","volume":"23","author":"J Bizzotto","year":"2020","unstructured":"Bizzotto J, Sanchis P, Abbate M, Lage-Vickers S, Lavignolle R, Toro A, et al. SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients. iScience. 2020;23(10):101585. https:\/\/doi.org\/10.1016\/j.isci.2020.101585.","journal-title":"iScience"},{"issue":"1","key":"13159_CR26","doi-asserted-by":"publisher","first-page":"e0261242","DOI":"10.1371\/journal.pone.0261242","volume":"17","author":"K Huang","year":"2022","unstructured":"Huang K, Wang C, Vagts C, Raguveer V, Finn PW, Perkins DL. Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis. PLoS ONE. 2022;17(1):e0261242. https:\/\/doi.org\/10.1371\/journal.pone.0261242. Published 2022 Jan 10.","journal-title":"PLoS ONE"},{"issue":"14","key":"13159_CR27","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/cvr\/cvaa284","volume":"116","author":"LA Bienvenu","year":"2020","unstructured":"Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020;116(14):2197\u2013206. https:\/\/doi.org\/10.1093\/cvr\/cvaa284.","journal-title":"Cardiovasc Res"},{"key":"13159_CR28","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.19.049254","author":"C Muus","year":"2020","unstructured":"Muus C, Luecken MD, Eraslan G, Waghray A, Heimberg G, Sikkema L, et al. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells. bioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.04.19.049254.","journal-title":"bioRxiv"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13159-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:45:21Z","timestamp":1779241521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13159-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13159"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13159-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Republic of T\u00fcrkiye, Ministry of Health, General Directorate of Health Services, COVID-19 Scientific Research Evaluation Commission (approval form no. 2020-10-30T12_52_33). Following this approval, ethical clearance was obtained from the Clinical Research Ethics Committee of Istanbul Medeniyet University, G\u00f6ztepe Prof. Dr. S\u00fcleyman Yal\u00e7\u0131n City Hospital (date: 18 November 2020; approval no. 2020\/06\/56). Written informed consent was obtained from all participants prior to inclusion in the study. All procedures involving human participants were conducted in accordance with the ethical standards of the relevant institutional and national research committees and with the Declaration of Helsinki (2013 revision).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"973"}}